Furthermore, although FAM167A was ectopically expressed in cells, FAM167A neutralizing antibody blocked the NF-κB activation, indicating that secreted FAM167A is the main inducer of NF-κB activation in CML cells. Here, NFKB1 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.